| Income Statement |
| Total Revenue | 3.21M |
|
| Revenues (USD) | 3.21M |
| Cost of Revenue | 3.01M |
| Gross Profit | 201.65K |
| Operating Expenses | 17.53M |
| Research and Development Expense | 492.23K |
| Selling, General and Administrative Expense | 3.91M |
| Operating Income | -17.33M |
| Net Income | -17.21M |
| Net Income Common Stock | -17.21M |
| Net Income Common Stock (USD) | -17.21M |
| Consolidated Income | -17.21M |
| Earnings per Basic Share | -0.87 |
| Earnings per Basic Share (USD) | -0.87 |
| Earnings per Diluted Share | -0.87 |
| Earning Before Interest & Taxes (EBIT) | -17.21M |
| Earning Before Interest & Taxes (USD) | -17.21M |
| Weighted Average Shares | 19.69M |
| Weighted Average Shares Diluted | 19.69M |
| Balance Sheet |
| Cash and Equivalents | 21.91M |
| Cash and Equivalents (USD) | 21.91M |
| Investments | 21.56M |
| Investments Current | 18.82M |
| Investments Non-Current | 2.75M |
| Trade and Non-Trade Receivables | 3.32M |
| Current Assets | 56.07M |
| Property, Plant & Equipment Net | 18.47M |
| Total Assets | 100.38M |
| Debt Current | 1.12M |
| Total Debt | 1.66M |
| Current Liabilities | 38.69M |
| Debt Non-Current | 535.17K |
| Total Liabilities | 66.33M |
| Accumulated Retained Earnings (Deficit) | -438.44M |
| Shareholders Equity | 34.05M |
| Shareholders Equity (USD) | 34.05M |
| Assets Non-Current | 44.31M |
| Total Debt (USD) | 1.66M |
| Deferred Revenue | 33.65M |
| Liabilities Non-Current | 27.64M |
| Trade and Non-Trade Payables | 2.49M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 182.27K |
| Net Cash Flow from Financing | 10.96M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.98M |
| Capital Expenditure | -17.10M |
| Issuance (Purchase) of Equity Shares | 10.83M |
| Issuance (Repayment) of Debt Securities | 386.40K |
| Net Cash Flow from Investing | -17.10M |
| Net Cash Flow from Operations | 21.12M |
| Share Based Compensation | 571.58K |